Loading...
XWAR
KRK
Market cap7.36bUSD
Dec 05, Last price  
866.00PLN
1D
0.23%
1Q
-2.91%
Jan 2017
249.19%
Name

Krka dd Novo Mesto

Chart & Performance

D1W1MN
XWAR:KRK chart
P/E
17.75
P/S
3.32
EPS
11.52
Div Yield, %
3.71%
Shrs. gr., 5y
-0.62%
Rev. gr., 5y
5.04%
Revenues
1.91b
+5.71%
1,010,021,0001,075,627,0001,143,301,0001,200,827,0001,191,614,0001,164,607,0001,174,424,0001,266,392,0001,331,858,0001,493,409,0001,534,941,0001,565,802,0001,717,453,0001,806,391,0001,909,544,000
Net income
357m
+13.71%
171,025,000162,801,000159,915,000172,836,000166,221,000158,245,000108,452,000152,600,000174,585,000245,545,000290,995,000309,214,000363,296,000313,946,000356,986,000
CFO
361m
+58.82%
181,516,000247,058,000278,329,000302,751,000170,870,000277,941,000213,492,000227,827,000289,952,000349,523,000360,759,000386,097,000467,651,000227,254,000360,933,000
Dividend
Jul 22, 202535.09583 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases; the gastrointestinal tract; central nervous system; pain relief; anti-infectives; blood and blood-forming organs; urological; diabetes; and oncology. The company also provides non-prescription products, such as products for oral cavity and pharynx; cough and cold products; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising antiinfectives, antiparasitics, and other products for farm and companion animals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.
IPO date
Feb 10, 1997
Employees
11,653
Domiciled in
SI
Incorporated in
SI

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT